7th Edition of Neurology World Conference 2027
Scientific Sessions - NWC 2027
Neuro oncology and Glioma
Gliomas are the most common malignant tumors that start in the brain, and they can cause confusion, memory loss, seizures, and movement problems. Because these tumors grow in the organ that shapes a person's memory, speech, and personality, every treatment decision carries extra weight. Molecular testing now helps classify tumors more accurately and guide treatment choices.
This track brings together the people treating gliomas, meningiomas, brain metastases, central nervous system (CNS) lymphoma, and nerve sheath tumors. Sessions cover molecular classification, advances in neurosurgery, radiotherapy, and targeted drug therapies.
Neuro-oncologists, neurosurgeons, radiation oncologists, pathologists, nurses, and researchers are invited to share work that improves both survival and daily life.
Topics include:
- Molecular diagnosis and WHO tumor classification
- Low-grade and high-grade gliomas
- Meningiomas and brain metastases
- Surgical and radiotherapy advances
- Targeted therapies and IDH inhibitors
- Immunotherapy and novel treatment approaches
- Tumor-related epilepsy and symptom control
- Supportive and palliative care
Join us in the effort to give patients longer and fuller lives.
Related Sessions
Neurology World Conference (NWC 2027): Promotes the talks in From Research to ...
Read More>>
Organizer
